Discovery of D3S-001, a highly potent and CNS-penetrant inhibitor of KRAS G12C with rapid and sustained target engagement kinetics

克拉斯 体内 药理学 癌症研究 药代动力学 医学 体外 癌症 化学 内科学 生物 生物化学 结直肠癌 生物技术
作者
J. Zhang,J. Lu,Z. Zheng,J. Lu,A. Wang,J. Wang,J. Chen,H. Rui,C. Chen,G. Chen
出处
期刊:European Journal of Cancer [Elsevier BV]
卷期号:174: S74-S74
标识
DOI:10.1016/s0959-8049(22)00998-4
摘要

Background: Covalent inhibition of mutant KRAS G12C protein by locking this oncogenic driver in its inactive state is clinically efficacious. Sotorasib and adagrasib have improved overall response rates (ORR) and progression-free survival (PFS) in patients with KRAS G12C-mutant non-small cell lung cancer (NSCLC). However, achieving deeper and more durable responses remain as challenges in targeting KRAS G12C. Treatment of brain metastasis in NSCLC remains a high unmet medical need. D3S-001, currently in a phase 1 trial (NCT05410145), is designed to improve clinical outcomes by optimizing KRAS G12C target engagement (TE). Here we report its preclinical activity, selectivity, central nervous system (CNS) penetrant properties, and predicted target inhibition at dose levels under phase 1 study. Material and methods: The kinetics of KRAS G12C TE was measured by GTP-RAS ELISA in tumor cells and xenografts. Covalent adduct formation with KRAS G12C protein was confirmed by LC-MS. D3S-001 selectivity was assessed by free-cysteine proteomics. Anti-proliferative effect on cancer cells was evaluated by the CTG assay. Cancer cell line- and patient-derived xenografts were utilized for in vivo efficacy studies. D3S-001 pharmacokinetics (PK) in plasma and cerebrospinal fluid (CSF) were investigated in beagle dogs. Human target inhibition was calculated based on human PK prediction, free drug fraction, and in vitro TE data. Results: D3S-001 demonstrates >95% target inhibition in cells at 2 hours at 5 nM and >97% at 6 hours after a single dose of 30 mg/kg in NCI-H358 tumors. D3S-001 is highly selective with KRAS G12C being the only peptide identified by proteomic profiling. D3S-001 inhibits growth of KRAS G12C-mutant cell lines with low nanomolar IC50s while no activity is seen with non-KRAS G12C mutant cells. Daily oral administration of D3S-001 at 30 and 100 mg/kg led to complete and durable tumor regression in NCI-H358 NSCLC and CR6256 colorectal cancer models, respectively. D3S-001 demonstrates a CSF-to-plasma Kp,uu value of 0.33, comparable to those of adagrasib and approved CNS-active small molecule inhibitors. Importantly, observed CSF concentrations of D3S-001 are sufficient to achieve >95% KRAS G12C TE. In phase 1, D3S-001 dose will be escalated from 50 mg to 900 mg QD. Predicted human exposures at dose levels >100 mg QD are expected to consistently achieve >95% target inhibition. At dose levels >400 mg QD, predicted exposures should achieve >95% target inhibition in CNS. Conclusions: D3S-001 demonstrates rapid and near complete TE with KRAS G12C in vitro and in vivo. Its potency, selectivity, and CNS-penetrance support clinical development in patients with KRAS G12C mutation. Optimal TE predicted at clinical exposures may lead to deeper and more durable responses in both systemic and intracranial tumors than currently available KRAS G12C inhibitors. No conflict of interest.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
开心妍发布了新的文献求助10
1秒前
2秒前
2秒前
欢020发布了新的文献求助10
2秒前
华仔的应助被xx采纳,获得10
3秒前
4秒前
yu发布了新的文献求助10
4秒前
岩岩岩完成签到,获得积分10
4秒前
4秒前
paul完成签到,获得积分20
5秒前
瑞幸不加冰完成签到,获得积分10
5秒前
林韬完成签到,获得积分10
5秒前
5秒前
walden完成签到,获得积分10
5秒前
阿白发布了新的文献求助10
5秒前
温柔的冰菱完成签到,获得积分10
5秒前
不孤单的sky完成签到,获得积分0
5秒前
6秒前
小猪哄哄发布了新的文献求助30
6秒前
rururu完成签到,获得积分10
6秒前
6秒前
ding的应助被mount819采纳,获得10
6秒前
明亮荔枝完成签到,获得积分10
6秒前
6秒前
7秒前
呆呆发布了新的文献求助10
7秒前
韩莉莎完成签到,获得积分10
7秒前
W溜溜梅完成签到 ,获得积分10
7秒前
孟祥雯发布了新的文献求助10
7秒前
7秒前
LQY完成签到,获得积分10
8秒前
jiajiajiajia完成签到,获得积分10
8秒前
上好佳发布了新的文献求助30
9秒前
9秒前
9秒前
9秒前
林韬发布了新的文献求助10
10秒前
夏天冷发布了新的文献求助10
10秒前
xx发布了新的文献求助10
11秒前
Jasper的应助被yy采纳,获得10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181155
求助须知:如何正确求助?哪些是违规求助? 9571140
关于积分的说明 21816740
捐赠科研通 7777528
什么是DOI,文献DOI怎么找? 3433436
关于科研通互助平台的介绍 2557664
邀请新用户注册赠送积分活动 2479482